Hi @RegularNinjaAs mentioned in my recent video (posted on HC if...

Hi @RegularNinja
As mentioned in my recent video (posted on HC if you want to review) and other announcements, our HCP marketing partner, Innorini, has been promoting Nasodine to Singapore doctors since November and the reaction has been extremely positive, which augurs well for sales an support through the GP/hospital channel. The Guardian people were also excited about Nasodine when we presented it to them in Singapore, so the potential is clearly there. As you point out, the launch through Guardian starting January is a big deal and an important inflection point for Firebrick. We will report the sales impact in our quarterly results.
In the meantime, it's hard to say what the market is waiting for; we have had several good announcements that telegraph the future upside and we have no discernible R&D, manufacturing or logistics risk. As I said in the video: "we have a fantastic runway ahead of us, and we're sitting at a very low price; it's a great opportunity for investors."